Douglas Fisher

Douglas Fisher

Corporate Officer/Principal chez SERA PROGNOSTICS, INC.

Fortune : 170 263 $ au 31/03/2024

48 ans
Health Technology
Health Services
Finance

Profil

Doug joined InterWest's healthcare team in 2009, focusing on biopharmaceutical, diagnostic and medical device investments, and portfolio company support.
He is a board member of Gynesonics and Indi Molecular and a former board member of Lycera, Obalon Therapeutics (NASDAQ: RSLS, acquired by ReShape Lifesciences) and PMV Pharma (NASDAQ GS: PMVP).
Doug is also actively involved in InterWest's investments in PMV Pharma (NASDAQ GS: PMVP), Potenza Therapeutics, Sera Prognostics (NASDAQ: SERA, where he serves as the Chief Business Officer), and Tizona Therapeutics.
Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments.
He was involved with several investments, including Pearl Therapeutics, Interlace Medical (Acquired by Hologic), and Stromedix (Acquired by Biogen Idec).
Prior to joining New Leaf, Doug was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area, consulting for leading pharmaceutical and biotech companies.
Previously, he worked for Centocor (a J&J operating company) in the Global Biologic Strategic Marketing Group.
Doug received an A.B.
in economics with honors and distinction, and a B.S.
in biology with distinction, from Stanford, where he graduated Phi Beta Kappa.
He has an M.D.
from the University of Pennsylvania School of Medicine and an M.B.A.
from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,29%
14/02/2024 43 300 ( 0,29% ) 132 931 $ 31/03/2024
27/10/2023 5 572 ( 0,39% ) 37 332 $ 31/03/2024

Postes actifs de Douglas Fisher

SociétésPosteDébut
SERA PROGNOSTICS, INC. Corporate Officer/Principal 29/04/2015
Founder -
Private Equity Investor 21/08/2020
Weavr Health Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tous les postes actifs de Douglas Fisher

Anciens postes connus de Douglas Fisher

SociétésPosteFin
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Douglas Fisher

Formation de Douglas Fisher

Stanford University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
Perelman School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Douglas Fisher

Relations

100 +

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
SERA PROGNOSTICS, INC.

Health Services

PMV PHARMACEUTICALS, INC.

Commercial Services

PRECIPIO, INC.

Health Services

Entreprise privées19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

Electronic Technology

Finance

Finance

Weavr Health

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Douglas Fisher